Researchers in Newcastle are seeking to find volunteers for a new clinical trial ...
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...
CDC data indicates that norovirus is back on the warpath and getting plenty of Americans sick.
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results